最新更新 :
28/04/2024
止痛药   Paracetamol  
注射液
口服剂 肛门塞剂
溶液稳定性 混合物稳定性 影响稳定性的因素 兼容性 用药途径 引用文献 PDF
   化学式  

商品名   商品名     

商品名仅供参考, 药品所用的辅料可能依国家或厂商不同有所不同。

Apotel 伊朗, 希腊
Axapara 厄瓜多尔
Eupifalgan 埃及
Febrinil 印度
Feveril 厄瓜多尔
Flashmol 智利
Imitimol 智利
Injectmol 埃及
Ofirmev 美国
Paraconica 瑞士
Parasedol 土耳其
Parol 土耳其
Partemol 土耳其
Perfalgan 丹麦, 冰岛, 土耳其, 埃及, 奥地利, 德国, 意大利, 挪威, 新西蘭, 沙特阿拉伯, 法国, 波兰, 爱尔兰, 瑞典, 瑞士, 突尼斯, 罗马尼亚, 芬兰, 英国, 荷兰, 葡萄牙, 西班牙, 阿联酋
Perfusalgan 卢森堡, 比利时
Raziphemol 卢森堡, 埃及, 比利时
Tempra 墨西哥
Vedraphen 埃及
引用文献   注射液   引用文献 : Paracetamol  
种类 出版物
150 文献 Aujoulat P, Coze C, Braguer D, Raybaud C.
Physicochemical compatibility of methotrexate with co-administered drugs during cancer chemotherapy regimens.
J Pharm Clin 1993 ; 12: 31-35.
2122 文献 Kambia NK, Luyckx M, Dine T, Dupin-Sriet T, Gressier B, Brunet C.
Stability and compatibility of paracetamol injection admixed with ketoprofen.
EJHP Science 2006 ; 12, 4: 81-84.
2140 文献 Kambia NK, Luyckx M, Dine T, Dupin-Spriet T, Gressier B, Brunet C.
Stability and compatibility of the ready-to-use solution of paracetamol admixted with phloroglucinol for intravenous infusion.
EJHP Science 2006 ; 12, 5: 91-95.
2231 文献 de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S.
Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection.
J Antimicrob Chemother 2008 ; 61, 2: 382-388.
3075 文献 Balayssac D, Badaroux L, Rodier C, Sautou-Miranda V, Bazin JE, Chopineau J.
Compatibility and stability of parenteral analgesic admixtures for multimodal analgesia
EJHP Science 2009 ; 15, 4: 78-82.
3315 海报 Louvrier M, Dhennain S, Hocahrt S, Zawadski E, Bouffart S, Moquay E.
Mise en évidence d'une incompatibilité physico-chimique entre la phénytoïne sodique et le paracétamol injectable en flacon.
Communication orale Hopipharm 2012
3350 文献 Kwiatkowski J.L, Johnson C.E, Wagner D.S.
Extended stability of intravenous acetaminophen in syringes and opened vials.
Am J Health-Syst Pharm 2012 ; 69:1999-2001
3372 文献 Hanci V, Ali Kiraz H, Ömür D, Ekin S, Uyan B, Yurtlu B.S.
Precipitation in Gallipoli: Sugammadex / Amiodarone & Sugammadex / Dobutamine & Sugammadex / Protamine.
Rev Bras Anestesiol 2013 ; 63, 1: 163-166.
3571 文献 Anderson C, Boehme S, Ouellette J, Stidham C, MacKay M.
Physical and Chemical Compatibility of Injectable Acetaminophen During Simulated Y-Site Administration.
Hosp Pharm 2014 ; 49, 1: 42-47.
3728 文献 Correard F, Savry A, Gauthier-Villano L, Pisano P, Pourroy B.
Visual compatibility of defibrotide with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2014 ; 71: 1288-1291.
3769 实验室 Paracatamol (Paracetamol B Braun®) - Résumé des caractéristiques du produit
B Braun laboratoire 2014
3824 文献 Boudi S, Roy H, Forest JM, Leclair G.
Compatibilité physique de l'association amoxicilline-acide clavulanique en injection avec plusieurs autres médicaments lors d'une administration en Y.
Pharmactuel 2023 2023;56,3:91-98
3879 文献 Foushee Jaime A, Meredith Pmichaele, Fox Laura M, Grace Edward E.
Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures.
Int J Pharm Compound 2016 ; 20, 4 : 328-332.
3948 文献 Bouchoud L, Fonzo-Christe C, Klingm?ller M, Bonnabry P .
Compatibility of Intravenous Medications With Parenteral Nutrition - In Vitro Evaluation.
JPEN 2012 ;30. 416?424.
3967 文献 Staven V, Herra I, Wang S, Grönlie I,Tho I.
Physical compatibility of total parenteral nutrition and drugs in Y-site administration to children from neonates to adolescents.
J Pharm Pharmacol 2017 ;69,7:448-462
3976 文献 Du Repaire T, Vigne P, Guedon A, Gauthier-Villano L, Bertault Peres P, Pourroy B.
Visual compatibility of blinatumomab with selected co-administrated drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2017 ; 74,16 : 1217-1218
3985 海报 Manai M., Soussi M.A., Lazreg O., Drira C., Ben Tekaya S. et Razgallah Khrouf M.
Compatibilité physique entre médicaments injectables et nutrition parentérale pédiatrique : Evaluation in-vitro.
Hopipharm Congress 2017 - Nancy 2017
4362 文献 Lopez Navarro AA, Martinez Gomez MA, Gras Colomer E, Campillos P, Climente Marti M.
Physicochemical stability of binary admixtures of paracetamol and dexketoprofen-trometamol for patient-controlled analgesia use.
EJHP 2018 Eur J Hosp Pharm 2018;0:1
4435 文献 Hanifah S, Nugroho B.H, Chabib L.
Compatibility of acetaminophen with central nervous system medications during simulated Y-site injection.
Anaesthesiol Intensive Ther 2020 ; 52, 1: 23-27.
4465 文献 Foushee A, Meredith P, Fox Laura, Wilder A.
Y-site physical compatibility of hydrocortisone continuous infusions with admixtures used in critically ill patients.
Am J Health-Syst Pharm 2020 ;77,14:1144-1148
4488 文献 Nezvalova-Henriksen K, Niklas Nilsson N, Tomine Østerberg C, Staven Berge V, Tho I.
Y-Site Physical Compatibility of Numeta G13E with Drugs Frequently Used at Neonatal Intensive Care.
Pharmaceutics 2020 ; 12, 677.
4521 文献 Polo C, D’Huart E, Lesperlette G, Vigneron J, Meyer F, Demoré B.
Compatibility of injectable posaconazole with drugs commonly used in a hematology care unit.
Pharmaceutical Technology in Hospital Pharmacy 2020
4543 文献 Senarathna G, Strunk T, Petrovski M, Batty K.
Physical compatibility of pentoxifylline and intravenous medications.
Archives of Disease in Childhood 2018 ;104:292–295.
4642 海报 Larossa garcia M, Jimenez-Lozano I, Boix-Montanés A, Mallandrich Miret M, Clemente Bautista M, cabanas Poy M.J., Gorgas Torner
Compatibilidad en Y de atosiban y farmacois habitualmente utilizados en obstetricia.
SEFH Congress (Virtual) October 2021 2021
4698 文献 Ayari G, D'Huart E, Vigneron J, Demoré B.
Y-site compatibility of intravenous medications commonly used in intensive care units : laboratory tests on 75 mixtures involving nine main drugs.
Pharmaceutical Technology in Hospital Pharmacy 2022
4742 文献 Macoviciuc M, Nguyen C, Forest J-M, Leclair G.
Compatibilité physique de l’acétaminophène injectable avec 102 autres médicaments lors d’une administration en Y.
Pharmactuel 2022 ; 55, 4: 247-255.

  Mentions Légales